Sanofi to publish Covid-19 vaccine price in development with GSK after Phase I/II trial results
The company is expected to release the results from the Phase I/II clinical trials this month
French drugmaker Sanofi will announce the price of the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.
The company is expected to release the results from the Phase I/II clinical trials this month.
It is also developing a vaccine with US biotech firm Translate Bio, with clinical human trials expected to start this month.